Restricted Access

Before you enter

All products are sold strictly for in-vitro laboratory research — not for human consumption, therapeutic, or veterinary use.

Your confirmation is saved for 7 days. You will only be asked to confirm once per week.
By entering you accept full responsibility for compliance with all applicable laws.

For research use only  ·  Not for human or animal consumption
Semax research vial Third-party tested
Cognitive & Neuroprotective Peptide

Semax

ACTH (4-10)
ACTH (4-7)-Pro-Gly-ProMet-Glu-His-Phe-Pro-Gly-ProMEHFPGP CAS 80714-61-0 Met-Glu-His-Phe-Pro-Gly-Pro

A synthetic heptapeptide analog of ACTH(4-10), studied for neurotrophin (BDNF) expression in laboratory models.

$30.00$6.00 / mg
Strength

Availability: 9 in stock

Fast U.S. shippingFree on orders over $200
Third-party testedIndependent lab, every batch
Purity documentedHPLC + mass spec
Secure checkoutVenmo · Cash App · Zelle
01Research snapshot

Semax, by the numbers.

Structural and laboratory facts that define this compound. For laboratory research use only.

0
Amino acid residues

Synthetic heptapeptide

0
Molecular weight

g/mol · C37H51N9O10S

0–7
ACTH positions

ACTH(4-7) core + Pro-Gly-Pro

0%+
Target purity

Reverse-phase HPLC

02Molecular structure

The Semax molecule

A schematic atomic representation shown next to the compound's molecular data. The figure is illustrative, not a measured conformation.

CHNOS
Molecular formula
C37H51N9O10S
Mol. weight813.9 g/mol
Sequence length7 residues
CAS80714-61-0
Physical formLyophilized powder
Purity99%+ HPLC
Use classResearch only
MetGluHisPheProGlyPro
03Mechanism of action

How it is studied.

Neuropeptide derived from ACTH with cognitive-enhancing and neuroprotective properties

01
Neurotrophic BDNF Modulation

Semax increases brain-derived neurotrophic factor (BDNF) levels by up to 1.4-fold in specific brain regions, supporting neuronal survival, growth, and synaptic plasticity.

  • Increases BDNF expression up to 1.4×
  • Supports neuronal survival and growth
  • Enhances synaptic plasticity
02
Neurotransmitter Serotonin & Dopamine Modulation

Research demonstrates Semax modulates serotonergic and dopaminergic systems, influencing mood regulation, attention, and cognitive processing in preclinical models.

  • Modulates serotonin metabolism
  • Influences dopaminergic signaling
  • Affects noradrenergic pathways
03
Neuroprotective Ischemic Protection

In ischemic stroke models, Semax demonstrates neuroprotective effects by reducing infarct volume, modulating inflammatory gene expression, and promoting neuronal survival under oxygen deprivation.

  • Reduces infarct volume in stroke models
  • Anti-inflammatory gene modulation
  • Protects neurons from oxidative stress

Research pathway map

The primary pathways Semax is investigated against in laboratory models.

SemaxTARGETS01Neurotrophic02Neurotransmitter03Neuroprotective
Illustrative schematic based on published in-vitro and preclinical observations. Research use only.
04Specifications

Compound details.

Chemical nameSemax (ACTH 4-7 Pro-Gly-Pro)
SynonymsACTH (4-10), ACTH (4-7)-Pro-Gly-Pro, Met-Glu-His-Phe-Pro-Gly-Pro, MEHFPGP
SequenceMet-Glu-His-Phe-Pro-Gly-Pro
FormulaC37H51N9O10S
Molecular weight813.9 g/mol
CAS number80714-61-0
FormLyophilized powder
DocumentationThird-party COA, per batch

Storage & handling

Supplied as a lyophilized powder. Store the sealed vial refrigerated at 2–8°C, protected from light and moisture; −20°C for long-term storage. Keep reconstituted material refrigerated.

FOR RESEARCH USE ONLYNot for human or animal consumption. Intended strictly for qualified researchers performing in-vitro or analytical laboratory work. No medical, diagnostic or therapeutic claims are made.
Brain Res · 2006Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus

BDNF and TrkB expression in rodent tissue.

Dolotov OV et al., 2006 · PubMed ↗
BMC Genomics · 2014The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis

Genome-wide expression in ischemia models.

Medvedeva EV et al., 2014 · PubMed ↗
0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Scroll to Top